British Society for Immunology (BSI) – Written evidence (COV0037)


The British Society for Immunology (BSI) represents over 4,200 immunologists working in academia, clinical medicine and industry. Our objective is to promote and support excellence in research, scholarship and clinical practice in immunology for the benefit of human and animal health. The BSI leads a taskforce, chaired by our President, Professor Arne Akbar, that aims to provide an expert voice on the immunology of COVID-19 to assist the response to the pandemic. The group’s first report is available here.






Vaccine development





Pandemic preparedness


Questions for further inquiry

The committee should investigate the B cell response to COVID-19, such as in the production of mediators that co-ordinate immune responses. It should also further investigate why people have different susceptibilities to the disease and what effect different variable factors have, e.g. ageing, BAME, obesity, children, and also what effect that these factors have on our immune systems’ responses to treatments and vaccines.


30 June 2020


[1] Cui et al. 2019. Origin and evolution of pathogenic coronaviruses. Nature Reviews Microbiology 17 181–192